C4 Therapeutics to Participate in Upcoming September Investor Conferences - C4 Therapeutics ( NASDAQ:CCCC )
WATERTOWN, Mass., Aug. 29, 2024 ( GLOBE NEWSWIRE ) -- C4 Therapeutics, Inc. ( C4T ) CCCC, a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that C4T management will participate in fireside chats at two September investor ...
| Ticker |
Sentiment |
Impact |
|
WFC
|
Neutral
|
13 %
|
|
CCCC
|
Somewhat Bullish
|
59 %
|
